Armata Pharmaceuticals (ARMP) to Release Earnings on Tuesday

Armata Pharmaceuticals (NYSEAMERICAN:ARMP - Get Free Report) is projected to release its earnings data before the market opens on Tuesday, May 6th. Analysts expect Armata Pharmaceuticals to post earnings of ($0.38) per share and revenue of $1.38 million for the quarter.

Armata Pharmaceuticals Trading Up 6.8 %

Shares of NYSEAMERICAN:ARMP traded up $0.09 during midday trading on Friday, hitting $1.44. 15,065 shares of the stock were exchanged, compared to its average volume of 11,734. Armata Pharmaceuticals has a twelve month low of $0.90 and a twelve month high of $3.45. The firm has a 50 day simple moving average of $1.47. The company has a market capitalization of $51.99 million, a PE ratio of -0.88 and a beta of 0.87.

Armata Pharmaceuticals Company Profile

Armata Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.